In the push to eliminate cervical cancer, researchers delivered hopeful news Nov. 17 at the 34th International Papillomavirus Conference in Toronto.
Two Department of Global Health faculty have been selected to lead the University of Washington/Fred Hutch Center for AIDS Research (CFAR). Professor Connie Celum and associate professor Ruanne Barnabas have been announced as the next Director and Co-Director, respectively.
Both appointments are active as of April 1, 2021.
Double Dose of Debate: Opinions Vary on Timing of COVID Vaccine Shots as Potential 4th Wave Looms (includes Ruanne Barnabas)
With COVID-19 vaccines still in limited supply and case counts threatening to resurge, there is a debate over the benefits of giving more people their first shot and waiting a longer time to administer the second dose, or whether to stay the course and prioritize getting both doses of the Pfizer and Moderna vaccine into arms as quickly as possible.
UW Students, Faculty Reveal New Strategies for Prevention & Treatment of Viral Infections at CROI 2021
At the 2021 Virtual Conference on Retroviruses and Opportunistic Infections (CROI), UW researchers shared groundbreaking research aimed at preventing and treating HIV and other sexually transmitted infections (STIs).
Study took place in KwaZulu Natal, South Africa, among 162 people living with HIV; findings presented at Virtual CROI 2021.
Home delivery of HIV medicines in South Africa significantly increased viral suppression compared to those who received clinical care, according to a study by researchers at the University of Washington School of Medicine.
Even partial protection of one dose could be enough to slow the spread of the virus, the UW Medicine researchers argue in a paper.
MEDIA CONTACT: Susan Gregg - 206.616.6730, email@example.com
Giving one dose of the COVID-19 vaccines currently approved in the United States could curtail the spread of the SARS-CoV-19 in the community more quickly than the recommended two doses, say two vaccine experts at the University of Washington School of Medicine.
Results to appear in Open Forum Infectious Diseases show hydroxychloroquine does not keep people from developing COVID-19.
MEDIA CONTACT: Susan Gregg, firstname.lastname@example.org, 206.390.3226
UW Medicine, Fred Hutch scientists will jointly test whether the monoclonal drug can prevent infection among people exposed to COVID-19.
Researchers at UW Medicine and the Fred Hutchinson Cancer Research Center are jointly testing monoclonal antibodies created by Regeneron Pharmaceuticals to prevent COVID-19, and are starting to recruit patients.
COVID-19 trials are short of enrollment - delaying much needed answers (Seattle Times, quotes Ruanne Barnabas and Christine Johnston)
One of the hottest debates in the coronavirus pandemic is whether the malaria drugs promoted as possible treatments by President Donald Trump really work. But Americans don’t seem overly eager to help answer the question.
Global Health Career Week, in collaboration with the School of Public Health, concluded with a Q&A panel on protecting public health during the COVID-19 pandemic. This live Zoom event provided participants with an opportunity to ask questions to our panel of experts.